Skip to main content
. 2022 May 11;10(5):e004420. doi: 10.1136/jitc-2021-004420

Table 3.

Multivariate analysis of prognostic factors for overall survival

Prognostic factors Cox hazard model
HR 95% CI P value
Tumor stage (recurrent after surgery and stage VI/recurrent-after chemoradiotherapy) 5.00 0.64 to 39.06 0.125
Performance status (2–3/0–1) 3.18 1.35 to 7.51 0.008
PD-L1 expression (50%–100%/0%–49%) 1.24 0.56 to 2.78 0.596
Monocyte (median) 0.64 0.29 to 1.40 0.264
Neutrophil:lymphocyte ratio (median) 2.17 0.75 to 6.25 0.151
Albumin (median) 1.59 0.68 to 3.69 0.283
Multivariate model (median) 3.55 1.47 to 8.59 0.005

Each prognostic factor for overall survival was evaluated by multivariate Cox proportional hazard analysis.